Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

747467

Sigma-Aldrich

Iron oxide(II,III) magnetic nanopowder

30 nm avg. part. size (TEM), NHS ester functionalized

Synonym(s):

Fe NP NHS, FexOy

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

UNSPSC Code:
12352302
NACRES:
NA.23

form

nanopowder
powder

composition

Fe, ~1.25 % (w/w)

magnetization

>45 emu/g, at room temperature; under 4500 Oe

color

light brown to dark brown, and Dark Grey

avg. part. size

30 nm (TEM)

functional group

NHS ester (functionalized)

storage temp.

−20°C

Looking for similar products? Visit Product Comparison Guide

Application

These magnetic nanoparticles are typically used in imaging or as contrast agents. The surface functionality allows for different ligation or further functionalization.

Legal Information

Product of Ocean Nanotech; LLC.

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications.
Laurent S, et al.
Chemical Reviews, 108(6), 2064- 2110 (2008)
The preparation of magnetic nanoparticles for applications in biomedicine.
Tartaj P, et al.
Journal of Physics D: Applied Physics, 36(13), R182-R182 (2003)
Eye, magnetism and magnets.
Richard Keeler et al.
The British journal of ophthalmology, 98(4), 425-426 (2014-05-02)
Yingjie Li et al.
Journal of bacteriology, 196(14), 2552-2562 (2014-05-06)
The biomineralization of magnetosomes in Magnetospirillum gryphiswaldense and other magnetotactic bacteria occurs only under suboxic conditions. However, the mechanism of oxygen regulation and redox control of biosynthesis of the mixed-valence iron oxide magnetite [FeII(FeIII)2O4] is still unclear. Here, we set
Aaron Harman et al.
Journal of computer assisted tomography, 38(4), 571-573 (2014-04-16)
Ferumoxytol is a parenteral iron therapy that the Food and Drug Administration recently approved for the treatment of iron-deficiency anemia. The form of the iron, ultrasmall superparamagnetic iron oxide nanoparticles, causes T1, T2, and T2* shortening on magnetic resonance imaging
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service